John Trainer
Chief Operating Officer presso IMMUNOCORE HOLDINGS PLC
Profilo
John Trainer currently works at Corvidia Therapeutics, Inc., as Director, Fujifilm Kyowa Kirin Biologics Co., Ltd., as Director, Archigen Biotech Ltd., as Director, and Immunocore Holdings Plc, as Chief Operating Officer & Senior Vice President from 2023.
Mr. Trainer also formerly worked at NexImmune, Inc., as Chief Financial Officer from 2020 to 2023 and AstraZeneca, Inc., as Vice President & Head-Partnering & Strategy.
Mr. Trainer received his Masters Business Admin degree from Harvard Business School and undergraduate degree from Harvard College.
Posizioni attive di John Trainer
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Chief Operating Officer | 01/10/2023 |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Director/Board Member | - |
Archigen Biotech Ltd.
 Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | Director/Board Member | - |
Fujifilm Kyowa Kirin Biologics Co., Ltd.
 Fujifilm Kyowa Kirin Biologics Co., Ltd. BiotechnologyHealth Technology Fujifilm Kyowa Kirin Biologics Co., Ltd. is a Japanese company that is not well described by the given metadata. The joint venture company is based in Tokyo, Japan. However, based on the company name, it is likely that they are involved in the biotechnology or pharmaceutical industry. The company was founded in 2012. The CEO is Yoshifumi Torii. | Director/Board Member | - |
Precedenti posizioni note di John Trainer
| Società | Posizione | Fine |
|---|---|---|
| NEXIMMUNE, INC. | Director of Finance/CFO | 02/09/2023 |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | - |
Formazione di John Trainer
| Harvard Business School | Masters Business Admin |
| Harvard College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NEXIMMUNE, INC. | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Aziende private | 4 |
|---|---|
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Health Technology |
Fujifilm Kyowa Kirin Biologics Co., Ltd.
Fujifilm Kyowa Kirin Biologics Co., Ltd. BiotechnologyHealth Technology Fujifilm Kyowa Kirin Biologics Co., Ltd. is a Japanese company that is not well described by the given metadata. The joint venture company is based in Tokyo, Japan. However, based on the company name, it is likely that they are involved in the biotechnology or pharmaceutical industry. The company was founded in 2012. The CEO is Yoshifumi Torii. | Health Technology |
Archigen Biotech Ltd.
Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | Health Technology |
- Borsa valori
- Insiders
- John Trainer
